Acute 0 5 0 5 O
cancer 6 12 6 12 B-cancer
treatment 13 22 13 22 B-treatment

Anyone 0 6 23 29 O
with 7 11 30 34 O
1 12 13 35 36 B-lower_bound
or 14 16 37 39 O
more 17 21 40 44 O
characteristics 22 37 45 60 O
of 38 40 61 63 O
frailty 41 48 64 71 O

Currently 0 9 72 81 O
followed 10 18 82 90 O
by 19 21 91 93 O
a 22 23 94 95 O
PCP 24 27 96 99 B-treatment
( 28 29 100 101 O
had 29 32 101 104 O
an 33 35 105 107 O
eval 36 40 108 112 O
in 41 43 113 115 O
last 44 48 116 120 B-upper_bound
6 49 50 121 122 I-upper_bound
- 50 51 122 123 I-upper_bound
months 51 57 123 129 I-upper_bound
) 57 58 129 130 O

Diagnosis 0 9 131 140 O
of 10 12 141 143 O
substance 13 22 144 153 O
abuse 23 28 154 159 O
or 29 31 160 162 O
dependence 32 42 163 173 O
( 43 44 174 175 O
last 44 48 175 179 O
12 49 51 180 182 O
months 52 58 183 189 O
) 58 59 189 190 O
, 59 60 190 191 O
excluding 61 70 192 201 O
Nicotine 71 79 202 210 B-upper_bound
dependence 80 90 211 221 I-upper_bound

End 0 3 222 225 B-chronic_disease
stage 4 9 226 231 I-chronic_disease
medical 10 17 232 239 I-chronic_disease
illness 18 25 240 247 I-chronic_disease
( 26 27 248 249 O
e.g. 27 31 249 253 O
liver 32 37 254 259 B-chronic_disease
, 37 38 259 260 O
kidney 39 45 261 267 B-chronic_disease
, 45 46 267 268 O
pulmonary 47 56 269 278 B-chronic_disease
) 56 57 278 279 O

HRSD>16 0 7 280 287 B-clinical_variable
and 8 11 288 291 O
a 12 13 292 293 O
DSM 14 17 294 297 B-chronic_disease
- 17 18 297 298 I-chronic_disease
IV 18 20 298 300 I-chronic_disease
depressive 21 31 301 311 I-chronic_disease
disorder 32 40 312 320 I-chronic_disease
( 41 42 321 322 O
e.g. 42 46 322 326 O
MDD 47 50 327 330 B-chronic_disease
, 50 51 330 331 O
Dysthymia 52 61 332 341 B-chronic_disease
) 61 62 341 342 O

History 0 7 343 350 O
of 8 10 351 353 O
allergic 11 19 354 362 O
or 20 22 363 365 O
adverse 23 30 366 373 O
reaction 31 39 374 382 O
to 40 42 383 385 O
escitalopram 43 55 386 398 B-allergy_name
or 56 58 399 401 O
duloxetine 59 69 402 412 B-allergy_name
, 69 70 412 413 O
or 71 73 414 416 O
non 74 77 417 420 O
- 77 78 420 421 O
response 78 86 421 429 O
to 87 89 430 432 O
adequate 90 98 433 441 O
trial 99 104 442 447 O
of 105 107 448 450 O
escitalopram 108 120 451 463 O
( 121 122 464 465 O
at 122 124 465 467 O
least 125 130 468 473 O
4 131 132 474 475 B-lower_bound
weeks 133 138 476 481 I-lower_bound
at 139 141 482 484 I-lower_bound
dose 142 146 485 489 I-lower_bound
of 147 149 490 492 I-lower_bound
20 150 152 493 495 I-lower_bound
mg 153 155 496 498 I-lower_bound
) 155 156 498 499 O
or 157 159 500 502 O
duloxetine 160 170 503 513 O
( 171 172 514 515 O
at 172 174 515 517 O
least 175 180 518 523 O
4 181 182 524 525 B-lower_bound
weeks 183 188 526 531 I-lower_bound
at 189 191 532 534 I-lower_bound
dose 192 196 535 539 I-lower_bound
of 197 199 540 542 I-lower_bound
90 200 202 543 545 I-lower_bound
mg 202 204 545 547 I-lower_bound
) 204 205 547 548 O

History 0 7 549 556 O
of 8 10 557 559 O
psychosis 11 20 560 569 B-chronic_disease
or 21 23 570 572 O
psychotic 24 33 573 582 B-chronic_disease
disorder 34 42 583 591 I-chronic_disease
or 43 45 592 594 O
bipolar 46 53 595 602 B-chronic_disease
disorder 54 62 603 611 I-chronic_disease

Mini 0 4 612 616 B-clinical_variable
Mental 5 11 617 623 I-clinical_variable
Exam 12 16 624 628 I-clinical_variable
< 17 18 629 630 O
24 19 21 631 633 B-upper_bound
or 22 24 634 636 O
a 25 26 637 638 O
diagnosis 27 36 639 648 O
of 37 39 649 651 O
dementia 40 48 652 660 B-chronic_disease

Patient 0 7 661 668 O
is 8 10 669 671 O
considered 11 21 672 682 O
a 22 23 683 684 O
significant 24 35 685 696 O
risk 36 40 697 701 B-chronic_disease
of 41 43 702 704 I-chronic_disease
suicide 44 51 705 712 I-chronic_disease

Subject 0 7 713 720 O
is 8 10 721 723 O
considered 11 21 724 734 O
based 22 27 735 740 O
on 28 30 741 743 O
history 31 38 744 751 O
to 39 41 752 754 O
be 42 44 755 757 O
unlikely 45 53 758 766 O
to 54 56 767 769 O
respond 57 64 770 777 O
to 65 67 778 780 O
the 68 71 781 784 O
single 72 78 785 791 O
agent 79 84 792 797 O
antidepressant 85 99 798 812 B-treatment
( 100 101 813 814 O
i.e. 101 105 814 818 O
, 105 106 818 819 O
subjects 107 115 820 828 O
with 116 120 829 833 O
treatment 121 130 834 843 B-treatment
resistant 131 140 844 853 O
depression 141 151 854 864 O
, 151 152 864 865 O
including 153 162 866 875 O
subjects 163 171 876 884 O
with 172 176 885 889 O
previous 177 185 890 898 B-treatment
treatment 186 195 899 908 I-treatment
with 196 200 909 913 O
ECT 201 204 914 917 B-treatment
) 204 205 917 918 O

